Eledon Pharmaceuticals, Inc.

NASDAQ:ELDN

4.35 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Revenue 0000.56000000000000.120.120000000000000000000000000000
Cost of Revenue 00.0970.0950.0940.0940.0940.0920.0930.0930.0940.0930.0610.0440.0440.0460000000000000000000.0010.0010.003000000000
Gross Profit 0-0.097-0.0950.466-0.094-0.094-0.092-0.093-0.093-0.094-0.093-0.061-0.044-0.044-0.0460.120.120000000000000000-0.001-0.001-0.003000000000
Gross Profit Ratio 0000.8320000000-507.333000110000000000000000000000000000
Reseach & Development Expenses 16.5210.1067.417.0677.9317.2018.1137.257.4525.7436.6356.1827.6584.2425.6533.0360.6150.8321.6481.3331.5092.2972.9892.741.6511.3291.0970.4930.5170.5330.3061.0366.1629.8957.9317.7338.4915.85510.5593.8042.8254.3923.5564.3492.704
General & Administrative Expenses 3.994.3963.4593.2713.2673.1532.9972.793.1463.543.2243.2032.8483.7293.3523.3223.7311.2691.730.9671.4111.7921.8861.8371.8481.861.69810.232.4486.1333.5862.7243.1463.683.5493.3393.4163.1272.7412.4573.5991.4931.3361.20.661
Selling & Marketing Expenses 00-0.095-0.09400000000000000000000000-8.61800000000000000000
SG&A 3.994.3963.3643.1773.2673.1532.9972.793.1463.543.2243.2032.8483.7293.3523.3223.7311.2691.730.9671.4111.7921.8861.8371.8481.861.6981.6122.4486.1333.5862.7243.1463.683.5493.3393.4163.1272.7412.4573.5991.4931.3361.20.661
Other Expenses 000.5740.7120.8490.7750.3380.3040.1270.036-0.00500.003-0.0010.0050.040.0040.0050.030.0230.027-0.004-0.0060.0030.0030-0.011-0.005-0.0050.0040.0110-0.418-0.07000000.0530.0340000
Operating Expenses 20.5114.50210.77410.24411.19810.35411.1110.0410.5989.2839.8599.38510.5067.9719.0056.3584.3462.1013.3782.32.924.0894.8754.5773.4993.1892.7952.1052.9656.6663.8923.769.30813.57511.4811.07211.9078.98213.36.2616.4245.8854.8925.5493.365
Operating Income -20.51-14.502-10.869-10.338-11.198-10.354-11.11-58.688-10.598-9.283-9.859-9.385-10.506-7.971-9.005-6.348-6.148-2.591-3.378-4.167-2.92-4.089-4.875-4.577-3.499-3.189-2.795-2.105-2.965-6.666-3.892-3.76-9.308-13.575-11.48-11.072-11.907-8.982-13.3-6.261-6.424-5.885-4.892-5.549-3.365
Operating Income Ratio 000-18.4610000000-78,208.333000-52.9-51.2330000000000000000000000000000
Total Other Income Expenses Net 97.481-30.405-12.7620.7120.849-55.4060.3380.3040.1270.036-0.00500.003-0.0010.0050.040.0040.005-4.7990.0230.027-0.004-0.0060.0030.0030-0.011-0.005-0.0050.0040.0260.0230.0380.0490.0540.0550.0540.0250.040.0530.0340.0340.0450.0240
Income Before Tax 76.971-44.907-10.295-9.626-10.349-9.579-10.772-58.384-10.471-9.247-9.864-9.385-10.503-7.972-9-6.308-6.144-2.586-8.177-4.144-2.893-4.093-4.881-4.574-3.496-3.189-2.806-2.11-2.97-6.662-3.866-3.737-9.27-13.526-11.426-11.017-11.853-8.957-13.26-6.208-6.39-5.851-4.847-5.525-3.365
Income Before Tax Ratio 000-17.1890000000-78,208.333000-52.567-51.20000000000000000000000000000
Income Tax Expense 000.0520.050.134-0.028-0.338-0.335-0.127-0.0360.005-0.579-0.686-0.588-0.501-0.4141.8020.494.8290000000000.005-0.003000000000-0.058-0.0390000
Net Income 76.971-44.907-10.295-9.626-10.349-9.579-10.434-58.049-10.344-9.211-9.869-8.806-9.817-7.384-8.499-5.904-6.144-2.586-8.177-4.144-2.893-4.093-4.881-4.574-3.496-3.189-2.806-2.11-2.97-6.662-3.866-3.737-9.27-13.526-11.426-11.017-11.853-8.957-13.26-6.208-6.39-5.851-4.847-5.525-3.365
Net Income Ratio 000-17.1890000000-73,383.333000-49.2-51.20000000000000000000000000000
EPS -0.34-1.06-0.34-0.4-0.35-0.4-0.73-4.21-0.73-0.65-0.69-0.62-0.66-0.5-0.57-8.19-5.51-2.74-8.52-5.75-4.01-6.27-9.32-8.74-6.68-6.1-6.52-5.47-7.7-28.86-168.24-26.74-2,051.79-3,127.4-81.81-79.18-85.19-64.72-95.97-45.04-439.18-45.65-51.13-1,814.45-1,105.09
EPS Diluted -0.32-1.06-0.34-0.4-0.35-0.4-0.73-4.21-0.73-0.65-0.69-0.59-0.66-0.5-0.57-8.19-5.51-2.74-8.52-5.75-4.01-6.27-9.32-8.74-6.68-6.1-6.52-5.47-7.7-28.86-168.24-26.74-2,051.79-3,127.4-81.81-79.18-85.19-64.72-95.97-45.04-439.18-45.65-51.13-1,814.45-1,105.09
EBITDA -20.431-14.405-10.774-10.244-11.104-10.26-11.018-9.947-10.505-9.189-9.766-9.324-10.462-7.927-8.959-6.263-5.379-2.099-3.332-2.298-2.874-4.044-4.83-4.574-3.496-3.187-2.792-2.106-2.968-6.662-1.381-3.72-9.308-0.922-11.427-11.125-11.875-8.966-13.295-6.256-6.419-5.878-4.888-5.546-3.361
EBITDA Ratio 000-18.2930000000-77,700000-52.692-20.8170000000000000000000000000000